Legacy Advisors, LLC Amylyx Pharmaceuticals, Inc. Transaction History
Legacy Advisors, LLC
- $918 Million
- Q3 2024
A detailed history of Legacy Advisors, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Legacy Advisors, LLC holds 50,000 shares of AMLX stock, worth $263,500. This represents 0.02% of its overall portfolio holdings.
Number of Shares
50,000
Previous 50,000
-0.0%
Holding current value
$263,500
Previous $95,000
70.53%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding AMLX
# of Institutions
127Shares Held
44.4MCall Options Held
235KPut Options Held
530K-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$24.5 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$16.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$14.1 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.13MShares$11.2 Million0.18% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL2.02MShares$10.7 Million0.04% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $308M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...